Showing results (231-240 of 252) with videos related to
Sort By:
Pageof 26
The Journal of Experimental Medicine|December 29, 2005
Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8/IFN consensus sequence-binding proteinChang Hoon Lee, Mark Melchers, Hongsheng Wang, et al.Journal of Autoimmunity|November 15, 2023
2023 International Consensus Guidance for the use of Tripterygium Wilfordii Hook F in the treatment of active rheumatoid arthritisXuan Zhang, Jun Xia, Ying Jiang, et al.JAMA|August 18, 2011
Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trialsJohn S Sundy, Herbert S B Baraf, Robert A Yood, et al.American Journal of Human Genetics|October 8, 2020
Analysis of Trans-Ancestral SLE Risk Loci Identifies Unique Biologic Networks and Drug Targets in African and European AncestriesKatherine A Owen, Andrew Price, Hannah Ainsworth, et al.Frontiers in Immunology|October 11, 2017
Spontaneous Secretion of the Citrullination Enzyme PAD2 and Cell Surface Exposure of PAD4 by NeutrophilsYebin Zhou, Bo Chen, Nanette Mittereder, et al.Arthritis and Rheumatism|July 27, 2006
Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosusLarissa Lapteva, Miroslawa Nowak, Cheryl H Yarboro, et al.Arthritis Research & Therapy|May 25, 2012
Aberrant CD200/CD200R1 expression and function in systemic lupus erythematosus contributes to abnormal T-cell responsiveness and dendritic cell activityYang Li, Li-dan Zhao, Lu-sha Tong, et al.Frontiers in Immunology|October 17, 2019
Identification and Characterization of Post-activated B Cells in Systemic Autoimmune DiseasesSarah Y Weißenberg, Franziska Szelinski, Eva Schrezenmeier, et al.The Journal of Pharmacology and Experimental Therapeutics|July 8, 2010
B-cell depletion in vitro and in vivo with an afucosylated anti-CD19 antibodyRonald Herbst, Yue Wang, Sandra Gallagher, et al.Annals of the Rheumatic Diseases|April 28, 2022
Biological impact of iberdomide in patients with active systemic lupus erythematosusPeter E Lipsky, Ronald van Vollenhoven, Thomas Dörner, et al.Pageof 26